Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2024-10-07 AGM Information
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Letter to Shareholders 1 page 191.5KB
AGM Information Classification · 95% confidence The document is a shareholder access letter for the 2024 Annual General Meeting (AGM) of Singular Health Group Ltd. It includes details about the meeting date, location, proxy form instructions, and how shareholders can access the Notice of Meeting and related materials online. The document does not contain the actual Notice of Meeting or any financial data, but rather directs shareholders to where these materials can be found. It is an announcement related to the AGM, providing logistical information and proxy voting instructions. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the AGM itself. The document length is under 5,000 characters and it does not contain the full report or financial statements, so it is not an Annual Report or Proxy Solicitation. Hence, the classification is AGM-R with high confidence.
2024-10-07 English
Divestment of Singular 3DP Printing Operations 2 pages 206.1KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 19 September 2024 regarding the sale of a subsidiary business (Singular 3DP Pty Ltd) by Singular Health Group. It details the terms of the sale, consideration, cost savings, and strategic rationale. There are no financial statements, regulatory certifications, or detailed financial performance data included. The content focuses on a corporate transaction related to divestment and business rationalisation, which fits the category of Capital/Financing Update (CAP). The document length is 3468 characters, which is relatively short but contains substantive information about a financing-related transaction rather than just a brief notice or report publication announcement. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-09-18 English
Appendix 4E and Annual Report to Shareholders 85 pages 3.9MB
Annual Report Classification · 100% confidence The document is titled 'Appendix 4E Preliminary final report' and includes detailed financial results for the year ended 30 June 2024, including revenues, losses, net tangible assets, and associates' details. It also mentions an audit with an unmodified opinion and states that the Annual Report for the year ended 30 June 2024 is attached. The document contains comprehensive financial statements, directors' report, auditor's report, corporate governance statement, and other detailed disclosures typical of a full annual report. The length is substantial (15,000 characters), and the content includes full financial data and analysis, not just an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K equivalent). FY 2024
2024-08-29 English
Appendix 4G and Corporate Governance Statement 27 pages 649.6KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a detailed key to corporate governance disclosures, indicating compliance with governance principles and recommendations for the financial year ended 30 June 2024. The document explicitly states it is not a substitute for the corporate governance statement but serves as a verification tool for disclosure requirements. It contains no financial statements or substantive financial data but focuses on governance disclosures and compliance. The document is lengthy (15,000 characters) and is a regulatory filing related to governance disclosures under ASX rules, not the actual corporate governance statement or annual report itself. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-29 English
Notification of cessation of securities - SHG 6 pages 18.4KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (expiry or lapse) of various securities such as options and performance rights for Singular Health Group Ltd. It includes specific security codes, reasons for cessation, and updated issued capital figures. The document is a formal announcement to the ASX about changes in the company's issued securities, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an announcement of changes in securities status. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-18 English
Technical Integration of Relu Dental AI Model 3 pages 249.2KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 8th August 2024 from Singular Health Group Ltd. It details the technical integration of a third-party dental AI model (Relu Dental AI Model) into the company's 3Dicom product suite, the commencement of a public API for third-party integrations, and commercial prospects. The content focuses on product development milestones, technical integration, and commercial licensing plans. There are no financial statements, earnings data, regulatory certifications, or voting results. The document is a corporate announcement about a technical and commercial development rather than a financial report or regulatory filing. It is not a report publication announcement since it contains substantive information about the integration and commercial strategy, not just a notice of report availability. Therefore, the best fitting category is Capital/Financing Update (CAP), as it relates to the company's progress in commercializing technology and potential revenue streams through licensing and pay-per-use models.
2024-08-07 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.